Real-world data reveals how a kidney drug impacts daily life and delays dialysis
Knowledge-focused
Completed
This study followed 530 adults with autosomal dominant polycystic kidney disease (ADPKD) who were already taking tolvaptan (JINARC™) as part of their routine care. Researchers measured how the drug affected patients' quality of life, pain, and ability to work, as well as how long…
Sponsor: Otsuka Canada Pharmaceutical Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC